Balchem Corporation (BCPC)

NASDAQ: BCPC · Real-Time Price · USD

157.30

0.75 (0.48%)

At close: May 01, 2025, 3:22 PM

0.48% (1D)

Bid	157.15
Market Cap	5.13B
Revenue (ttm)	964.54M
Net Income (ttm)	136.54M
EPS (ttm)	4.17
PE Ratio (ttm)	37.72
Forward PE	30.8
Analyst	Buy

Ask	157.5
Volume	111,625
Avg. Volume (20D)	186,201
Open	156.31
Previous Close	156.55
Day's Range	155.14 - 157.43
52-Week Range	143.47 - 186.03
Beta	0.75

About BCPC

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the...

[Read more]

Industry Chemicals - Specialty

Sector Basic Materials

IPO Date Jun 3, 1986

Employees 1,379

Stock Exchange NASDAQ

Ticker Symbol BCPC

Website https://www.balchem.com

Full Company Profile

Analyst Forecast

According to 1 analyst ratings, the average rating for BCPC stock is "Buy." The 12-month stock price forecast is $180, which is an increase of 14.43% from the latest price.

Stock Forecasts

Earnings Surprise

Balchem has released their quartely earnings on Apr 24, 2025:

Revenue of $250.52M exceeds estimates by $4.82M, with 4.53% YoY growth.

EPS of 1.22 misses estimates by 0.00, with 18.45% YoY growth.

Why Price Moved

1 week ago

-2.6%

Balchem shares are trading lower. The company repo... Unlock content with Pro Subscription

6 months ago

+3.19%

Balchem shares are trading higher after the company reported better-than-expected Q3 adjusted EPS results.

News

1 week ago · seekingalpha.com

Balchem Corporation (BCPC) Q1 2025 Earnings Call Transcript

Balchem Corporation (NASDAQ:BCPC ) Q1 2025 Earnings Conference Call April 24, 2025 11:00 AM ET Company Participants Martin Bengtsson - CFO Ted Harris - Chairman, President & CEO Conference Call Partic...

6 days ago · zacks.com

Blachem (BCPC) Lags Q1 Earnings Estimates

Blachem (BCPC) came out with quarterly earnings of $1.22 per share, missing the Zacks Consensus Estimate of $1.25 per share. This compares to earnings of $0.89 per share a year ago.

2 weeks ago · zacks.com

Blachem (BCPC) Upgraded to Strong Buy: Here's Why

Blachem (BCPC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

2 months ago · seekingalpha.com

Balchem Is A Great Company, But I'm Still Waiting For A Better Entry

Balchem Corporation specializes in performance ingredients across nutrition, food, pharmaceuticals, and animal health, but its high P/E ratio and rising costs warrant a "Hold" rating. Q4 2024 saw mode...

2 months ago · seekingalpha.com

Balchem Corporation (BCPC) Q4 2024 Earnings Conference Call Transcript

Balchem Corporation (NASDAQ:BCPC ) Q4 2024 Earnings Conference Call February 21, 2025 11:00 AM ET Company Participants Martin Bengtsson - CFO Ted Harris - Chairman, President and CEO Conference Call P...

2 months ago · zacks.com

Blachem (BCPC) Lags Q4 Earnings and Revenue Estimates

Blachem (BCPC) came out with quarterly earnings of $1.03 per share, missing the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $0.82 per share a year ago.